25-Hydroxycholesterol as a Basis for Senolytic Therapy

25-hydroxycholesterol is an oxidized form of cholesterol, and researchers here demonstrate that it is senolytic to some degree in mice. This may be competitive with existing first generation senolytics; from the paper, it looks like it clears about half of the excess of senescent cells present in old mice, in muscle tissue at least. Like all other senolytics, its effectiveness likely varies widely by tissue type and location in the body. Oxidized cholesterols are largely thought to be harmful in the body, particularly because they can cause macrophages to become dysfunctional and accelerate the progression of atherosclerosis. It is unclear as to whether that could prove to be a blocking issue at the sort of doses and schedules used in senolytic therapy.

Researchers have shown that the endogenous metabolite 25-hydroxycholesterol (25HC) significantly reduced the burden of senescent cells in multiple cell types in both mice and human cell culture, and in live mice, where it showed particular efficacy in skeletal muscle. "Given that 25HC shares no common molecular motifs with other senolytics, it appears that this molecule represents a brand new class of potential interventions."

25HC is a little understood oxidized lipid involved in cholesterol metabolism. The team identified it after discovering that the molecule disrupted cellular senescence in CRYAB, a small heat shock protein which was upregulated upon senescence in nine different cell types from two species, mice and humans. Diseases associated with CRYAB include myopathies, diseases that affect muscles that control voluntary movement in the body.

Working in mouse and human cell cultures researchers isolated specific cell types from skeletal muscle, made them senescent and showed that 25HC could kill them selectively. The team then went on to test 25HC in aged mice; experiments showed 25HC improved their muscle mass. Researchers also determined that 25HC killed senescent cells in mouse dermal fibroblasts, and in primary human cells from the lung, heart, liver, kidney, and articular cartilage. "We are intending to use this molecule in multiple paradigms of aging and we're hoping that other researchers will start testing it as well."

Link: https://www.buckinstitute.org/news/a-naturally-occurring-metabolite-is-a-potent-senolytic-in-both-mice-and-human-cell-culture/


Isn't cholesterol practically insoluble in water? What would be the bioavailability?

So far it seems that many senolytic s are basically mild poisons which happen to kill senescent cells much better than the regular ones.

It was overdue to find more senolytic compounds. For the last few years we were stuck mostly with navitoclax , D+Q and fisetin.

Posted by: Cuberat at February 9th, 2022 4:35 PM

Cuberat, you are absolutely right about mild poisons, and at the beginning of the 20th century there was a test for cell senescence - old cells died under the action of dilute hydrocyanic acid, but young ones did not. Later, a myth appeared about the Khundza tribe who prolonged life by eating apricot seeds with amygdalin (vitamin B17). By releasing hydrocyanic acid, amygdalin acted as a non-cumulative poison - a senolytic. Unfortunately, too much hope for B17, named Laetrile, in terms of cancer treatment has discredited it and drowned out its possible usefulness as a senolytic.

Posted by: Dmitry Dzhagarov at February 10th, 2022 1:22 AM
Comment Submission

Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.